News
STROKE AF at 3 years: High AFib rate after atherosclerotic stroke
- Author:
- Sue Hughes
Continuous monitoring to detect AFib should be considered in a larger population of stroke patients rather than just those with cryptogenic stroke...
News
Brain differences suggest therapeutic targets in Takotsubo
- Author:
- Sue Hughes
A new study has identified differences in the brain between patients with Takotsubo syndrome, a cardiomyopathy triggered by intense emotional...
News
Warfarin best for thrombotic antiphospholipid syndrome?
- Author:
- Sue Hughes
A vitamin K antagonist such as warfarin, rather than a direct oral anticoagulant, appears to be a better treatment for patients with thrombotic...
News
Is thrombolysis safe for stroke patients on DOACs?
- Author:
- Sue Hughes
“Our results suggest that current guidelines need to be revised to remove the absolute contraindication of thrombolysis in patients on DOACs.”
News
Cardiac injury caused by COVID-19 less common than thought
- Author:
- Sue Hughes
Study examines cardiac MRI scans in 31 patients before and after having COVID-19.
News
‘Reassuring’ data on pregnancy with ischemic heart disease
- Author:
- Sue Hughes
The risk associated with isolated preexisting ischemic heart disease without additional evidence of cardiomyopathy was relatively similar to that...
News
The 'Plaque Hypothesis': Focus on vulnerable lesions to cut events
- Author:
- Sue Hughes
A new strategy is needed that targets unstable plaque in the whole of the coronary arteries, rather than just obstructive lesions, to reduce major...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Ishani_Areef_MINN_web.jpg)
Chlorthalidone, HCTZ equally effective in hypertension: DCP published
- Author:
- Sue Hughes
The Diuretic Comparison Project trial, showing no difference in clinical events between diuretics chlorthalidone and hydrochlorothiazide for...
News
Statins tied to lower ICH risk regardless of bleed location
- Author:
- Sue Hughes
A large new case-control study has shown a reduced risk of both lobar and nonlobar intracerebral hemorrhage with statin use, providing reassurance...
News
Analysis suggests CV benefits for some antioxidant supplements
- Author:
- Sue Hughes
“Identifying the optimal mixture of micronutrients is important, as not all are beneficial.”
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Morris_Pamela_SC_web.jpg)
Lp(a) tied to more early CV events than familial hypercholesterolemia
- Author:
- Sue Hughes
Higher levels of lipoprotein(a) are associated with risk similar to that seen with familial hypercholesterolemia, but with risk starting as low as...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Piazza_Gregory_Boston3_web.jpg)
No benefit of rivaroxaban in COVID outpatients: PREVENT-HD
- Author:
- Sue Hughes
PREVENT-HD joins a long list of smaller trials also showing no benefit of anticoagulation in nonhospitalized COVID-19 patients.
News
Four-drug combo gets BP down in one step: QUARTET-USA
- Author:
- Sue Hughes
The combination product containing quarter doses of four different drugs reduced blood pressure by almost 5 mm Hg more than a standard dose of one...
News
New trial suggests CV benefit with EPA: RESPECT-EPA
- Author:
- Sue Hughes
The open-label trial could add some support to findings from the REDUCE-IT study, which showed a reduction in cardiovascular events with high-dose...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Bozkurt_Biykem_TX_web_0.jpg)
Diuretic agents equal to prevent CV events in hypertension: DCP
- Author:
- Sue Hughes
Cardiovascular events were nearly identical with two different hypertension drugs in the randomized Diuretic Comparison Project trial.